| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LIF | Common stock | Sale | -$7.27M | -269K | -12.19% | $27.00* | 1.94M | 07 Jun 2024 | Direct | F1 |
| transaction | LIF | Common stock | Sale | -$533K | -19.8K | -65.95% | $27.00* | 10.2K | 07 Jun 2024 | Held by ICCA Labs, LLC | F2, F3 |
| Id | Content |
|---|---|
| F1 | Includes 86,554 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
| F2 | Represents shares of the Issuer's common stock underlying 30,603 Chess Depositary Interests ("CDIs"). The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. |
| F3 | The Reporting Person is a member of ICCA Labs, LLC, an entity that holds an aggregate of 45,425 shares of the Issuer's common stock underlying 136,275 CDIs. The number of shares sold and held as reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC. |